Printed from acutecaretesting.org
Articles by J. M. Lorenz
Showing articles by "J. M. Lorenz"
Article
January 2016
POCT: Taking control in uncontrolled premises, part 2
Point-of-care testing (POCT) covers a broad range of pathology and non-pathology testing. The volume of POCT is rapidly increasing with an annual growth rate of 12-15 %.
By virtue of its compactness, portability, and the feasibility of operation by non-laboratory personnel, where fast and accurate testing methods and...
Point-of-care testing
Process optimization
Quality assurance
Glucose
Hemoglobins
Article
July 2015
Comparing D-dimer assays using likelihood ratios and Fagan nomograms
Clinical sensitivity, clinical specificity and predictive values are frequently used as performance measure for a biochemistry assay. When D-dimer assay performance is presented, emphasis is often on the negative predictive value (NPV).
However, predictive values are greatly influenced by the prevalence of the...
Information management
Coagulation/fibrinolysis
D-dimer
Article
July 2015
POCT: Taking control in uncontrolled premises
With the ultimate goal of improving patient care, adoption of point-of-care testing (POCT) continues to grow at a high rate. The ability to deliver fast and reliable results near the patient is a key driver for improving patient outcomes and optimizing clinical workflow.
While there are many advantages, controlling...
Point-of-care testing
Process optimization
Quality assurance
Glucose
Hemoglobins
Article
April 2015
Update on Procalcitonin Measurements
Reprinted from Ann Lab Med 2014 Sep; 34(4):263-73.
Procalcitonin (PCT) is used as a biomarker for the diagnosis of sepsis, severe sepsis and septic shock. At the same time, PCT has also been used to guide antibiotic therapy. This review outlines the main indications for PCT measurement and points out possible...
Infection/sepsis
PCT
CRP
Kidneys/fluids
Article
December 2014
Role of POCT in the management of patients with acute dyspnea
This short review aims to put the diagnostic options provided by state-of-the-art POCT technology into perspective with the clinical challenges faced by physicians treating patients presenting with acute dyspnea.
Natriuretic peptides, hemoglobin, D-dimers and venous blood gases play a key role in the early...
Cardiac markers
Blood gases/acid-base
Hemoglobins
Natriuretic peptide
Article
October 2014
Point-of-care cardiac markers in the Emergency Department are safe, reduce admissions and do not impact on the 4-hour target
Barnsley Emergency Department (ED), which recruited patients into the RATPAC trial, initiated a point-of-care (POC) pathway for low-risk chest pain patients from December 2011.
All patients who underwent POC testing for chest pain between December 2011 and July 2012 were identified. Patient notes were then examined...
Cardiac markers
Point-of-care testing
Process optimization
Troponins
Article
July 2014
The value of point-of-care testing in deteriorating ward patients
Point-of-care testing (POCT) for key laboratory variables may help clinicians assess the level of acuteness and the level of care necessary in the management of deteriorating ward patients.
We used a multibiomarker POCT panel including B-type natriuretic peptide (BNP), D-dimer, myoglobin (Myo), creatine kinase MB...
Cardiac markers
Point-of-care testing
Coagulation/fibrinolysis
D-dimer
Troponins
Natriuretic peptide
Kidneys/fluids
Article
May 2014
Laboratory use of umbilical cord blood for critically ill infants
Neonates nearly always experience their single largest day of blood loss on the day of birth due to admission laboratory testing. The term "admission laboratory testing" refers to the initial blood tests done when a baby is born and admitted to the NICU.
Total circulating blood volume in a 3.5 kg term newborn is 280...
Point-of-care testing
Blood gases/acid-base
Hemoglobins
Article
October 2013
Age-adjustment of the D-dimer cut-off value to improve the exclusion of thromboembolic events in older patients
With increasing age, an unspecific rise of fibrin degradation product in blood is observed. Thus, the D-dimer test to rule out thromboembolic events has a high false positive rate in elderly patients.
In 2010, Douma et al introduced a formula to adjust D-dimer cut-off values for age in outpatients >50 years: Age ×...
Coagulation/fibrinolysis
D-dimer
Article
September 2013
Developing quality control strategies based on risk management: The CLSI EP23 guideline
How do errors occur in the laboratory and what can we do to prevent errors?
Any test can and will fail if incorrectly performed or operated under the wrong conditions. The role of the laboratory director is to determine those conditions and to understand test limitations in order to prevent laboratory errors....
Point-of-care testing
Quality assurance
Hemoglobins
D-dimer
Troponins
